# Home Bancorp, Inc.: financial statements, quarterly

HBCP · Nasdaq · CIK 1436425 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hbcp.md) · [Financials](/companies/hbcp/financials.md) · [Filings](/companies/hbcp/filings.md) · [Insiders](/companies/hbcp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hbcp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [12.6](/filings/0001436425-24-000009.md) | [14.1](/filings/0001436425-24-000009.md) | [15.2](/filings/0001436425-24-000016.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [2.5](/filings/0001628280-26-015669.md) | [2.1](/filings/0001628280-26-015669.md) | [2.2](/filings/0001628280-26-015669.md) | [2.0](/filings/0001628280-26-015669.md) | [2.2](/filings/0001628280-26-015669.md) | [2.3](/filings/0001628280-26-015669.md) | [2.8](/filings/0001628280-26-031198.md) | [2.8](/filings/0001628280-26-051688.md) | [3.2](/filings/0001628280-26-015669.md) | [3.1](/filings/0001628280-26-015669.md) | [3.0](/filings/0001628280-26-031198.md) | [2.8](/filings/0001628280-26-051688.md) |
| Net income | $m | [9.8](/filings/0001628280-26-015669.md) | [9.4](/filings/0001628280-26-015669.md) | [9.2](/filings/0001628280-26-015669.md) | [8.1](/filings/0001628280-26-015669.md) | [9.4](/filings/0001628280-26-015669.md) | [9.7](/filings/0001628280-26-015669.md) | [11.0](/filings/0001628280-26-031198.md) | [11.3](/filings/0001628280-26-051688.md) | [12.4](/filings/0001628280-26-015669.md) | [11.4](/filings/0001628280-26-015669.md) | [11.4](/filings/0001628280-26-031198.md) | [11.6](/filings/0001628280-26-051688.md) |
| Diluted EPS | $ per share | [1.22](/filings/0001628280-26-015669.md) | [1.17](/filings/0001628280-26-015669.md) | [1.14](/filings/0001628280-26-015669.md) | [1.02](/filings/0001628280-26-015669.md) | [1.18](/filings/0001628280-26-015669.md) | [1.21](/filings/0001628280-26-015669.md) | [1.37](/filings/0001628280-26-031198.md) | [1.45](/filings/0001628280-26-051688.md) | [1.59](/filings/0001628280-26-015669.md) | [1.46](/filings/0001628280-26-015669.md) | [1.45](/filings/0001628280-26-031198.md) | [1.48](/filings/0001628280-26-051688.md) |
| Basic EPS | $ per share | [1.22](/filings/0001628280-26-015669.md) | [1.18](/filings/0001628280-26-015669.md) | [1.15](/filings/0001628280-26-015669.md) | [1.02](/filings/0001628280-26-015669.md) | [1.19](/filings/0001628280-26-015669.md) | [1.22](/filings/0001628280-26-015669.md) | [1.38](/filings/0001628280-26-031198.md) | [1.47](/filings/0001628280-26-051688.md) | [1.60](/filings/0001628280-26-015669.md) | [1.48](/filings/0001628280-26-015669.md) | [1.47](/filings/0001628280-26-031198.md) | [1.49](/filings/0001628280-26-051688.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [3,318](/filings/0001436425-23-000054.md) | [3,320](/filings/0001436425-25-000012.md) | [3,358](/filings/0001436425-24-000016.md) | [3,411](/filings/0001436425-24-000033.md) | [3,442](/filings/0001436425-24-000039.md) | [3,444](/filings/0001628280-26-015669.md) | [3,485](/filings/0001436425-25-000018.md) | [3,491](/filings/0001436425-25-000036.md) | [3,494](/filings/0001628280-25-048166.md) | [3,493](/filings/0001628280-26-051688.md) | [3,555](/filings/0001628280-26-031198.md) | [3,603](/filings/0001628280-26-051688.md) |
| Total liabilities | $m | [2,972](/filings/0001436425-23-000054.md) | [2,953](/filings/0001436425-25-000012.md) | [2,985](/filings/0001436425-24-000016.md) | [3,035](/filings/0001436425-24-000033.md) | [3,049](/filings/0001436425-24-000039.md) | [3,048](/filings/0001628280-26-015669.md) | [3,083](/filings/0001436425-25-000018.md) | [3,083](/filings/0001436425-25-000036.md) | [3,071](/filings/0001628280-25-048166.md) | [3,058](/filings/0001628280-26-051688.md) | [3,110](/filings/0001628280-26-031198.md) | [3,150](/filings/0001628280-26-051688.md) |
| Shareholders' equity | $m | [345](/filings/0001436425-24-000039.md) | [367](/filings/0001628280-26-015669.md) | [372](/filings/0001436425-25-000036.md) | [376](/filings/0001628280-25-048166.md) | [393](/filings/0001628280-25-048166.md) | [396](/filings/0001628280-26-051688.md) | [403](/filings/0001628280-26-051688.md) | [409](/filings/0001628280-26-051688.md) | [423](/filings/0001628280-25-048166.md) | [435](/filings/0001628280-26-051688.md) | [444](/filings/0001628280-26-051688.md) | [453](/filings/0001628280-26-051688.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [13.1 d](/filings/0001436425-24-000039.md) | [10.2 d](/filings/0001628280-26-015669.md) | [10.3](/filings/0001436425-25-000018.md) | [15.0 d](/filings/0001436425-25-000036.md) | [17.6 d](/filings/0001628280-25-048166.md) | [5.8 d](/filings/0001628280-26-015669.md) | [12.6](/filings/0001628280-26-031198.md) | [8.7 d](/filings/0001628280-26-051688.md) | [21.5 d](/filings/0001628280-25-048166.md) | [11.7 d](/filings/0001628280-26-015669.md) | [16.8](/filings/0001628280-26-031198.md) | [11.2 d](/filings/0001628280-26-051688.md) |
| Capital expenditure | $m | [0.4 d](/filings/0001436425-24-000039.md) | [0.5 d](/filings/0001628280-26-015669.md) | [1.3](/filings/0001436425-25-000018.md) | [1.6 d](/filings/0001436425-25-000036.md) | [0.6 d](/filings/0001628280-25-048166.md) | [0.5 d](/filings/0001628280-26-015669.md) | [3.9](/filings/0001628280-26-031198.md) | [0.8 d](/filings/0001628280-26-051688.md) | [0.8 d](/filings/0001628280-25-048166.md) | [4.6 d](/filings/0001628280-26-015669.md) | [2.4](/filings/0001628280-26-031198.md) | [1.9 d](/filings/0001628280-26-051688.md) |
| Dividends paid | $m | [2.0 d](/filings/0001436425-24-000039.md) | [2.0 d](/filings/0001628280-26-015669.md) | [2.0](/filings/0001436425-25-000018.md) | [2.0 d](/filings/0001436425-25-000036.md) | [2.0 d](/filings/0001628280-25-048166.md) | [2.1 d](/filings/0001628280-26-015669.md) | [2.2](/filings/0001628280-26-031198.md) | [2.1 d](/filings/0001628280-26-051688.md) | [2.3 d](/filings/0001628280-25-048166.md) | [2.4 d](/filings/0001628280-26-015669.md) | [2.4](/filings/0001628280-26-031198.md) | [2.4 d](/filings/0001628280-26-051688.md) |
| Share repurchases | $m | [1.2 d](/filings/0001436425-24-000039.md) | [0.5 d](/filings/0001628280-26-015669.md) | [0.8](/filings/0001436425-25-000018.md) | [2.8 d](/filings/0001436425-25-000036.md) | [1.0 d](/filings/0001628280-25-048166.md) | [0.1 d](/filings/0001628280-26-015669.md) | [7.8](/filings/0001628280-26-031198.md) | [6.5 d](/filings/0001628280-26-051688.md) | [(0.0) d](/filings/0001628280-25-048166.md) | [0.0 d](/filings/0001628280-26-015669.md) | [0.2](/filings/0001628280-26-031198.md) | [0.2 d](/filings/0001628280-26-051688.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [8,138](/filings/0001436425-23-000054.md) | [8,137](/filings/0001436425-24-000016.md) | [8,079](/filings/0001436425-24-000033.md) | [8,039](/filings/0001436425-24-000039.md) | [8,039](/filings/0001436425-25-000018.md) | [8,019](/filings/0001436425-25-000036.md) | [7,967](/filings/0001628280-25-048166.md) | [8,027](/filings/0001628280-26-031198.md) | [7,781](/filings/0001628280-26-051688.md) | [7,783](/filings/0001628280-25-048166.md) | [7,827](/filings/0001628280-26-031198.md) | [7,853](/filings/0001628280-26-051688.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 7,870,750 at 2026-07-31, from the cover of the [10-Q filed 2026-08-03](/filings/0001628280-26-051688.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.